Jane Street’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-14,779
| Closed | -$232K | – | 10426 |
|
|
2024
Q1 | $232K | Sell |
14,779
-76,794
| -84% | -$1.18M | ﹤0.01% | 7955 |
|
|
2023
Q4 | $1.48M | Sell |
91,573
-6,244
| -6% | -$79.6K | ﹤0.01% | 4848 |
|
|
2023
Q3 | $1.24M | Buy |
97,817
+30,794
| +46% | +$425K | ﹤0.01% | 4846 |
|
|
2023
Q2 | $944K | Buy |
67,023
+12,170
| +22% | +$174K | ﹤0.01% | 5274 |
|
|
2023
Q1 | $847K | Buy |
54,853
+26,435
| +93% | +$441K | ﹤0.01% | 5328 |
|
|
2022
Q4 | $466K | Sell |
28,418
-48,445
| -63% | -$788K | ﹤0.01% | 6257 |
|
|
2022
Q3 | $1.42M | Buy |
76,863
+55,303
| +257% | +$868K | ﹤0.01% | 4786 |
|
|
2022
Q2 | $284K | Sell |
21,560
-42,765
| -66% | -$472K | ﹤0.01% | 7697 |
|
|
2022
Q1 | $596K | Sell |
64,325
-72,738
| -53% | -$619K | ﹤0.01% | 7143 |
|
|
2021
Q4 | $1.34M | Buy |
137,063
+113,310
| +477% | +$2.13M | ﹤0.01% | 5325 |
|
|
2021
Q3 | $808K | Buy |
+23,753
| New | +$758K | ﹤0.01% | 6339 |
|
|
2021
Q1 | – | Sell |
-21,099
| Closed | -$982K | – | 9708 |
|
|
2020
Q4 | $1.21M | Buy |
21,099
+5,642
| +37% | +$334K | ﹤0.01% | 4360 |
|
|
2020
Q3 | $793K | Buy |
15,457
+8,286
| +116% | +$406K | ﹤0.01% | 4471 |
|
|
2020
Q2 | $428K | Buy |
+7,171
| New | +$384K | ﹤0.01% | 5317 |
|
|
2020
Q1 | – | Sell |
-14,872
| Closed | -$926K | – | 6145 |
|
|
2019
Q4 | $926K | Buy |
14,872
+8,620
| +138% | +$410K | ﹤0.01% | 2886 |
|
|
2019
Q3 | $212K | Buy |
+6,252
| New | +$185K | ﹤0.01% | 4592 |
|
|
2018
Q3 | – | Sell |
-28,264
| Closed | -$1.11M | – | 5849 |
|
|
2018
Q2 | $1.11M | Buy |
+28,264
| New | +$832K | ﹤0.01% | 2608 |
|
Other funds holding DCPH
Jane Street's DCPH Position: Q2 2024 in Review
Jane Street sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 14,779 shares — an estimated $232K sold.
Jane Street first reported a position in DCPH in Q2 2018 and held it in 17 quarters. The position peaked at $1.48M in Q4 2023. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Jane Street reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Jane Street sold 14,779 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $232K.
- Jane Street first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 17 quarters.
- Jane Street's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.48M in Q4 2023.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Jane Street's 13F filing for Q2 2024, filed 15 Aug 2024.